Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Stanford Center for Connecting DNA Variants to Function and PhenotypeUM1HG011972 · NHGRI · STANFORD UNIVERSITY · PI JESSE M ENGREITZ, THOMAS QUERTERMOUS · 2021 to 2026
$10.5M
Scientific Core: Perturb-seq library generation, sequencing, and data analysisP01HL180323 · NHLBI · STANFORD UNIVERSITY · PI THOMAS QUERTERMOUS · 2025 to 2026
$7.1M
Causal variant association mechanisms in TCF21 binding coronary disease lociR01HL134817 · NHLBI · STANFORD UNIVERSITY · PI THOMAS QUERTERMOUS · 2017 to 2026
$6.2M
Predicting context-specific molecular and phenotypic effects of genetic variation through the lens of the cis-regulatory codeU01HG012069 · NHGRI · STANFORD UNIVERSITY · PI Anshul Kundaje · 2021 to 2026
$3.9M
The SMAD3 signaling network in coronary artery disease riskR01HL139478 · NHLBI · STANFORD UNIVERSITY · PI THOMAS QUERTERMOUS · 2018 to 2026
$3.7M
Gene regulatory networks controlling smooth muscle phenotype and vasculardisease riskR01HL171045 · NHLBI · STANFORD UNIVERSITY · PI THOMAS QUERTERMOUS · 2024 to 2026
$2.1M
The role of Twist1 in SMC phenotypic modulation during atherosclerosisR01HL171275 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Robert Wirka · 2024 to 2026
$1.5M
Adventitial Fibroblast Phenotypic Modulation in AtherosclerosisR01HL179083 · NHLBI · STANFORD UNIVERSITY · PI Paul Po Sheng cheng · 2025 to 2026
$1.4M
Smad3-mediated gene-environment interaction and risk of tobacco-induced aneurysmsR01HL181441 · NHLBI · STANFORD UNIVERSITY · PI Philip S Tsao, Paul Po Sheng cheng · 2025 to 2026
$1.4M
The role of TWIST1 in smooth muscle cells during atherosclerosisK08HL152308 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WIRKA, ROBERT · 2020 to 2024
$765k
ADAR mediated RNA editing is a causal mechanism in coronary artery diseaseK08HL167699 · NHLBI · STANFORD UNIVERSITY · PI Chad S Weldy · 2023 to 2026
$664k
ZEB1 Mediated Coronary Artery Disease Risk in Vascular Smooth MuscleK08HL177173 · NHLBI · STANFORD UNIVERSITY · PI DANIEL YUHANG LI · 2025 to 2026
$331k
NHLBI NIH HHS F32 HL165819NHLBI NIH HHS F32 HL165854NHLBI NIH HHS K08 HL167699NHLBI NIH HHS K08 HL177173NHLBI NIH HHS K08 HL177251NHLBI NIH HHS L30 HL159413NHLBI NIH HHS L70 HL175747NHLBI NIH HHS P01 HL180323U.S. Department of Health & Human Services | National Institutes of Health (NIH) F32HL165819U.S. Department of Health & Human Services | National Institutes of Health (NIH) K08HL152308U.S. Department of Health & Human Services | National Institutes of Health (NIH) K08HL167699U.S. Department of Health & Human Services | National Institutes of Health (NIH) K08HL177251U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01HL134817U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01HL139478U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01HL171045U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01HL171275U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01HL179083U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01HL181441U.S. Department of Health & Human Services | National Institutes of Health (NIH) U01HG012069U.S. Department of Health & Human Services | National Institutes of Health (NIH) UM1HG011972
6 · The paper itself
Abstract
Vascular smooth muscle cells contribute to heritable coronary artery disease risk and undergo complex transitions to multiple disease-related phenotypes. To investigate the genetic basis of these trajectories, we develop a dense timecourse single-cell transcriptomic and epigenetic map of atherosclerosis in a murine disease model accompanied by high-plex in situ spatial data. Using temporal data and probabilistic fate modeling, we identify key transcription factors that drive cell state changes through a combination of network-based prioritization and in silico transcription factor perturbation. Parallel knockout studies of validated coronary artery disease gene Tcf21 uncover its molecular mechanisms in smooth muscle cell transition, due in part to a role regulating the transition of smooth muscle cells in the secondary heart field. Integrating the murine atlas with human coronary artery disease genetics pinpoint smooth muscle cell phenotypes that mediate disease risk, highlighting causal disease mechanisms. Together, these studies resolve atherosclerosis trajectories at single-cell resolution and identify genetic causal transcriptomic and epigenomic mechanisms of coronary artery disease risk.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.